Our PRODUCTS

An investigational triple agonist targeting the GLP-1, GIP, and glucagon receptors. Studied in preclinical and clinical research for effects on metabolic regulation, glucose handling, and body-weight endpoints. Still investigational; not an approved drug.

A dual GIP/GLP-1 receptor agonist. Extensively studied in metabolic and glycemic research. Widely characterized in the literature for its incretin-pathway mechanism.

A synthetic analog of growth-hormone-releasing hormone (GHRH). Research focuses on stimulation of endogenous growth-hormone secretion and downstream IGF-1 signaling, including studies on visceral adipose tissue.

A selective growth-hormone secretagogue (ghrelin-receptor agonist). Studied for its ability to stimulate GH release with relatively low effect on cortisol and prolactin in research models.

A GHRH analog, often studied alongside secretagogues. Research examines its extended half-life (particularly the DAC-modified form) and sustained stimulation of GH/IGF-1 pathways.

A mitochondrial-derived peptide. Research investigates its role in metabolic homeostasis, insulin sensitivity, and AMPK-pathway signaling in cellular and animal models.

A synthetic fragment corresponding to a region of Thymosin β4. Studied in preclinical models for actin regulation, cell migration, and tissue-repair pathways.

A synthetic peptide derived from a gastric protein sequence. Studied preclinically for effects on angiogenesis and tissue-healing pathways; largely animal-model data, not established in humans.

A tripeptide (glutamate–cysteine–glycine) and major intracellular antioxidant. Research covers redox balance, oxidative-stress modulation, and detoxification pathways.

A synthetic tetrapeptide based on the pineal peptide epithalamin. Research explores telomerase activity, circadian/pineal regulation, and aging markers, mostly in animal and cell studies.

A copper-binding tripeptide (glycyl-L-histidyl-L-lysine complexed with copper). Studied for roles in tissue remodeling, collagen synthesis, and wound-healing pathways; also used in topical cosmetic research.

 A synthetic mitochondria-targeting tetrapeptide that selectively binds cardiolipin on the inner mitochondrial membrane. Research examines its role in stabilizing mitochondrial structure, supporting electron-transport/ATP efficiency, and reducing reactive oxygen species, with studies spanning mitochondrial dysfunction, ischemia-reperfusion, and cardiac and age-related models. Still investigational; largely preclinical data. 

 A coenzyme present in all living cells, central to cellular energy metabolism and redox reactions. Research examines its role in mitochondrial function, sirtuin-pathway signaling, DNA repair, and the age-related decline in cellular NAD+ levels, largely in cellular and animal models. Not a peptide.